Fresenius Medical Care AG & Co. KGaA (FMCQF)
USD 45.38
(0.0%)
USD 45.38
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.62 Billion | 2.31 Billion | 2.82 Billion | 5.17 Billion | 2.88 Billion | 2.06 Billion |
| Net Income | 732.45 Million | 720.71 Million | 1.1 Billion | 1.42 Billion | 1.34 Billion | 1.98 Billion |
| Depreciation & Amortization | 1.75 Billion | -1.84 Billion | -1.8 Billion | -1.94 Billion | -1.74 Billion | 724.84 Million |
| Deferred income taxes | -122.14 Million | -44.38 Million | 76.44 Million | 135.94 Million | 72.13 Million | 89.17 Million |
| Stock-based compensation | 32.51 Million | -5.87 Million | 28.29 Million | 40.89 Million | 1.99 Million | 10.74 Million |
| Change in working capital | 561.27 Million | -137.06 Million | -111.12 Million | 1.11 Billion | -440.59 Million | -54.44 Million |
| Other non-cash items | 336.42 Million | -297.04 Million | -323.24 Million | 230.44 Million | 3.64 Billion | 1.09 Billion |
| Investing Cash Flow | -544.22 Million | -691.61 Million | -1.29 Billion | -1.57 Billion | -3.61 Billion | -177.84 Million |
| Investments in PPE | -684.59 Million | -824.45 Million | -1 Billion | -1.32 Billion | -1.3 Billion | -1.14 Billion |
| Acquisitions | 136.99 Million | 209.12 Million | -218.94 Million | -168.92 Million | -2.28 Billion | 1.4 Billion |
| Investment purchases | -102.36 Million | -138.01 Million | -234.25 Million | -131.28 Million | -38.84 Million | -590.19 Million |
| Sales/Maturities of investments | 89.59 Million | 61.72 Million | 164.26 Million | 51.68 Million | 18.65 Million | 150.17 Million |
| Other Investing Activities | 16.13 Million | 1.00 | 0.24 | 0.74 | 0.06 | 79 Thousand |
| Financing Cash Flow | -1.85 Billion | -1.82 Billion | -1.22 Billion | -3.31 Billion | -600.26 Million | -748.93 Million |
| Debt repayment | -1.74 Billion | -366.94 Million | -384.24 Million | -687.86 Million | -1.12 Billion | -160.92 Million |
| Dividends payments | -328.62 Million | -395.55 Million | -392.45 Million | -351.17 Million | -354.63 Million | -324.83 Million |
| Common Stock Repurchased | - | -829.6 Million | -792.18 Million | -447.8 Million | -673.27 Million | -37.22 Million |
| Common Stock Issuance | - | 21.56 Million | 7.4 Million | 15.48 Million | 17.8 Million | 47.4 Million |
| Other Financing Activities | 212.46 Million | -227.37 Million | 387.88 Million | -1.76 Billion | 1.58 Billion | -595.2 Million |
| Accounts receivables | -151.84 Million | -49.96 Million | -185.49 Million | 87.72 Million | -71.96 Million | -170.49 Million |
| Accounts payables | 108.47 Million | -9.33 Million | 22.38 Million | -19.95 Million | -40.25 Million | 4.48 Million |
| Inventory | -13.14 Million | -218.65 Million | -55.16 Million | -435.37 Million | -131.89 Million | -157.09 Million |
| Other working capital | 617.78 Million | 140.89 Million | 107.14 Million | 1.48 Billion | -196.48 Million | 268.65 Million |
| Cash at beginning of period | 1.27 Billion | 1.48 Billion | 1.08 Billion | 1 Billion | 2.14 Billion | 978.1 Million |
| Cash at end of period | 1.42 Billion | 1.27 Billion | 1.48 Billion | 1.08 Billion | 1 Billion | 2.14 Billion |
| Capital Expenditure | -684.59 Million | -824.45 Million | -1 Billion | -1.32 Billion | -1.3 Billion | -1.14 Billion |
| Effect of forex changes on cash | -72.6 Million | -23.16 Million | 131.22 Million | -160.37 Million | 47.76 Million | 32.38 Million |
| Net cash flow / Change in cash | 153.43 Million | -207.86 Million | 400.11 Million | 73.81 Million | -1.13 Billion | 1.16 Billion |
| Free Cash Flow | 1.94 Billion | 1.49 Billion | 1.82 Billion | 3.85 Billion | 1.57 Billion | 919.53 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 187.02 Million | 118.31 Million | 207.5 Million | 732.45 Million | 89.16 Million | 153.09 Million |
| Depreciation & Amortization | 383.76 Million | 512.44 Million | 444.17 Million | 1.75 Billion | 415.05 Million | 442.91 Million |
| Deferred income taxes | -46.16 Million | -44.36 Million | -36.01 Million | -122.14 Million | -32.74 Million | -39.44 Million |
| Stock-based compensation | - | - | 32.51 Million | 32.51 Million | - | - |
| Change in working capital | 113.59 Million | -420.83 Million | 134.92 Million | 561.27 Million | 347.03 Million | 489.1 Million |
| Other non-cash items | 386.77 Million | 88.18 Million | 950.98 Million | 336.42 Million | -911.76 Million | -835.32 Million |
| Investing Cash Flow | 328.25 Million | -68.36 Million | -91.61 Million | -544.22 Million | -151.3 Million | -123.83 Million |
| Investments in PPE | -165.18 Million | -133.9 Million | -282.07 Million | -684.59 Million | -151.8 Million | -180.48 Million |
| Acquisitions | 512.99 Million | 40.57 Million | 214.08 Million | 136.99 Million | 11.62 Million | 21.68 Million |
| Investment purchases | -303 Thousand | -188 Thousand | -10.94 Million | -102.36 Million | -37.7 Million | -18.09 Million |
| Sales/Maturities of investments | -18.35 Million | 20.73 Million | -12.68 Million | 89.59 Million | 26.57 Million | 53.06 Million |
| Other Investing Activities | -892 Thousand | 892 Thousand | 135.83 Million | 16.13 Million | 1.00 | 32.12 Million |
| Financing Cash Flow | -843.07 Million | -289.65 Million | -837.9 Million | -1.85 Billion | -444.29 Million | -787.92 Million |
| Debt repayment | -7.96 Million | -514.13 Million | -576.7 Million | -1.74 Billion | -174.79 Million | -205.26 Million |
| Dividends payments | -349.16 Million | - | - | -328.62 Million | - | -328.62 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -330.18 Million | 224.47 Million | -261.19 Million | 212.46 Million | -269.5 Million | -224.21 Million |
| Accounts receivables | -10.86 Million | -552.72 Million | -83.67 Million | -151.84 Million | -50.75 Million | 358.66 Million |
| Accounts payables | 210.98 Million | 126.59 Million | 17.21 Million | 108.47 Million | -9.56 Million | 8.47 Million |
| Inventory | -15.15 Million | -40.99 Million | 46.9 Million | -13.14 Million | 58.19 Million | -24.3 Million |
| Other working capital | -71.36 Million | 187.18 Million | 154.48 Million | 617.78 Million | 349.15 Million | 146.27 Million |
| Cash at beginning of period | 1.14 Billion | 1.42 Billion | 1.64 Billion | 1.27 Billion | 1.48 Billion | 1.32 Billion |
| Cash at end of period | 1.09 Billion | 1.19 Billion | 1.54 Billion | 1.42 Billion | 1.64 Billion | 1.48 Billion |
| Capital Expenditure | -165.18 Million | -133.9 Million | -282.07 Million | -684.59 Million | -151.8 Million | -180.48 Million |
| Effect of forex changes on cash | -7.72 Million | -4.51 Million | -24.04 Million | -72.6 Million | 16.73 Million | -33.83 Million |
| Net cash flow / Change in cash | -58.04 Million | -235.23 Million | -92.83 Million | 153.43 Million | 157.1 Million | 158.35 Million |
| Free Cash Flow | 277.23 Million | -6.59 Million | 511.59 Million | 1.94 Billion | 651.32 Million | 918.04 Million |
FRAM-B
PRCNF
7229
GOZ
CRTTF
NMT